EcoDrugPlus

5-Hydroxytryptamine (Serotonin) Receptor 3b

Ensembl ID : ENSMSIG00000012863
Gene Symbol: HTR3B
1 Cross references
189 Possible Orthologues:

5-Hydroxytryptamine (Serotonin) Receptor 5a

Ensembl ID : ENSMSIG00000027945
Gene Symbol: HTR5A
1 Cross references
225 Possible Orthologues:

5-Hydroxytryptamine (Serotonin) Receptor 6

Ensembl ID : ENSMSIG00000014275
Gene Symbol: HTR6
1 Cross references
129 Possible Orthologues:

5-Hydroxytryptamine (Serotonin) Receptor 7

Ensembl ID : ENSMSIG00000023360
Gene Symbol: HTR7
1 Cross references
234 Possible Orthologues:

Atp-Binding Cassette, Sub-Family B (Mdr/tap), Member 1b

Ensembl ID : ENSMSIG00000008476
Gene Symbol: ABCB1B
1 Cross references
163 Possible Orthologues:

Atp-Binding Cassette, Sub-Family C (Cftr/mrp), Member 1

Ensembl ID : ENSMSIG00000020982
Gene Symbol: ABCC1
1 Cross references
216 Possible Orthologues:

Atp-Binding Cassette, Sub-Family C (Cftr/mrp), Member 8

Ensembl ID : ENSMSIG00000026529
Gene Symbol: ABCC8
1 Cross references
252 Possible Orthologues:

Atp-Binding Cassette, Sub-Family C (Cftr/mrp), Member 9

Ensembl ID : ENSMSIG00000019881
Gene Symbol: ABCC9
1 Cross references
244 Possible Orthologues:

Atpase, H+/k+ Exchanging, Beta Polypeptide

Ensembl ID : ENSMSIG00000005950
Gene Symbol: ATP4B
1 Cross references
199 Possible Orthologues:

Atpase, H+/k+ Exchanging, Gastric, Alpha Polypeptide

Ensembl ID : ENSMSIG00000006805
Gene Symbol: ATP4A
1 Cross references
198 Possible Orthologues:

Atpase, Na+/k+ Transporting, Alpha 1 Polypeptide

Ensembl ID : ENSMSIG00000017781
Gene Symbol: ATP1A1
1 Cross references
337 Possible Orthologues:

Atpase, Na+/k+ Transporting, Alpha 2 Polypeptide

Ensembl ID : ENSMSIG00000008038
Gene Symbol: ATP1A2
1 Cross references
220 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).